Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders


Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s):  MBGNF

Med Biogene Inc is a development stage life science company. The Company is engaged in the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer.
Price: $0.05 | Change: $0.00 | %Change: 0.00%
Volume: 43,000 | Day High/Low: 0.05/0.05 | 52 Week High/Low: 0.105/0.03
View modes: 
5 stars

RE:Need news

Hire IR @ .08,3 months in @ .05.Total waste of time.WJ,a year in,nothing as well.  rate and reply
2 stars


Exactly.  rate and reply
1 star


If the last NR wasn't clear enough, I don't understand what would have changed dramatically over the last 60 days - we are well ahead of where we were last year at this time, so patience is clearly more
0 stars

Need news

yes we need something from management very soon. From my understanding with new management, would of kept us in the loop.not been s really good job..... Hopefully we get some positive news.  rate and reply
5 stars

RE:RE:MBI Appointment of Investor Relations and Business Advisory

I like to try and give Management the benefit of the doubt first. In this case, it seems you are correct with your assumption, 60+ days in. The stock and activity reflect the lack of news.  rate and reply
5 stars

RE:MBI Appointment of Investor Relations and Business Advisory

Northerner, this is what I was pointing out when IR was announced. In my experience a waste of money. 60k is a lot for mbi. Really not liking this move. Only thing to move this stock is payer more
0 stars


could we please get some sort Of update from management. I ve got my finger's crossed on this one. This seems to be doing nothing.  rate and reply
5 stars

MBI Appointment of Investor Relations and Business Advisory

60 days into this 6 month process, what value has this investment generated for Shareholders and MBI? We're looking at a decreased in daliy volume and share price. From my perspective, I'm not more
0 stars

Set up to run

I think the stock is set up to run higher. 5c may have been the pullback low. I'm pleasantly surprised that it has hung in there with no positive news. Q4 is still a ways away, I'm wondering if more
0 stars

RE:RE:RE:Accumulators are Where?

British, could not agree more, been saying this for months. If and when it comes, I think the sp will climb significantly - with or without IR.  rate and reply
0 stars

RE:RE:Accumulators are Where?

We need news on payers, That is the most important piece of the puzzle right now. Information on a product launch is only significant once we have payers on board to provide the financial more
0 stars

RE:Accumulators are Where?

Agreed!  rate and reply
0 stars

Accumulators are Where?

Gee, never mind the next run to 10, hopefully this thing will go to the 50s and beyond so we can quit our shatty awful temp. jobs - that this ridiculous economy has provided - for good.  rate and reply
5 stars

Accumulate on Weakness

Traders ride this up, and then short it down.  Traders ride this up and, and then short it down.  The trend continues here and this will be a great add to the core position in the coming months. more
1 star

A stellar performance...

I would think that the cost of doing the 3000 share trade exceeded any gains made on said trade.  rate and reply
0 stars

RE:RE:RE:WJ Getting Some Ink

No impact on price short term. Again, I think the only thing that will significantly impact price is insurer coverage and commercialization.  rate and reply
0 stars

New Product  rate and reply
1 star

Raising Awareness

Iain Weir Jones is in a position not that common in Canadian business: he took the reins of TSX-Venture listed, Med Bio-Gene Inc. less than one year back following a extended proxy battle. And more
0 stars

RE:RE:WJ Getting Some Ink

Good press, now let's see if it impacts share price.  rate and reply
0 stars

RE:WJ Getting Some Ink

Looks like our investor relations hire is bearing fruit.  rate and reply